DETROIT, April 10, 2017 /PRNewswire-USNewswire/ -- Katrina D. Studvent, MSW, has accepted the position of chief development officer at the Barbara Ann Karmanos Cancer Institute, effective April 10. She reports directly to Karmanos President & CEO Gerold Bepler, M.D., Ph.D.
"Katrina brings significant expertise and experience to her new role at Karmanos, especially in the areas of corporate and community relations, and resource development," said Dr. Bepler. "Her leadership will guide philanthropic efforts to secure support that enhances patient care, innovative and ground-breaking cancer research, and capital projects."
As chief development officer, Studvent is responsible for ensuring that philanthropy and fund development are carried out in keeping with the organization's mission and vision. She will provide leadership, oversight and philanthropic stewardship and will manage the day-to-day operations of the Development Department. She will also work closely with corporate and community leaders, major gift officers, charitable foundations, and board members and other volunteers to effectively cultivate and generate philanthropic support.
Studvent has been with Karmanos since 2010 and previously served as director of Breast Cancer Special Programs, as well as director and race chair of the Susan G. Komen Detroit Race for the Cure®, of which Karmanos has been the local presenting sponsor for 26 years. The Komen Detroit Race is Michigan's largest breast cancer event, which has raised and invested more than $29 million in the breast cancer fight, supporting local programs and national breast cancer research.
Studvent will maintain her leadership of this year's race, happening May 13 at Comerica Park, while assuming her new role as chief development officer.
"I am thrilled to continue my work with the Barbara Ann Karmanos Cancer Institute as chief development officer," Studvent said. "I believe wholeheartedly in Karmanos' mission of one day eradicating all cancers. I look forward to working with our contributors whose generosity benefits cancer patients who entrust their care to our doctors and medical teams."
As a breast cancer survivor herself, Studvent has experienced first-hand the emotional, financial and physical challenges one faces when they receive a cancer diagnosis.
"Ten years ago, I was treated for breast cancer at the Karmanos Cancer Institute and 10 years later I am extremely proud to assume a role that will allow me to further my support of and strong belief in Karmanos' progressive work," she said.
Studvent serves on several boards and committees, including the newly formed Komen Greater Detroit Affiliate Board of Directors. She also serves as an Advocate in Science for Susan G. Komen; a member of the Detroit HealthLink Advisory and Oversight Committee; and serves on the Michigan Cancer Consortium's Membership and Health Equity committees.
She is a member of the Sisters Network Inc. - Greater Metro Detroit Chapter; member of the Women's Committee at the Charles H. Wright Museum of African American History; and a group facilitator at Gilda's Club Metro Detroit.
She has received numerous awards, including the Michigan Chronicle Women of Excellence Award in 2016; SHE's Empowered Leadership Award in 2015; Girl Scouts of Southeastern Michigan One Tough Cookie Award in 2015; and the Barbara Ann Karmanos Heroes of Breast Cancer Geri Lester Award in 2009.
Studvent received a Master of Social Work degree from the University of Michigan with a focus in Non-Profit Management and earned her bachelor's degree in Political Science from James Madison College at Michigan State University.
About the Barbara Ann Karmanos Cancer Institute
Located in mid-town Detroit, Michigan, the Barbara Ann Karmanos Cancer Institute, a subsidiary of McLaren Health Care, is one of 47 National Cancer Institute-designated comprehensive cancer centers in the United States. Karmanos is among the nation's best cancer centers. Through the commitment of 1,000 staff, including nearly 300 physicians and researchers on faculty at the Wayne State University School of Medicine, and supported by thousands of volunteer and financial donors, Karmanos strives to prevent, detect and eradicate all forms of cancer. Its long-term partnership with the WSU School of Medicine enhances the collaboration of critical research and academics related to cancer care. Gerold Bepler, M.D., Ph.D., is the Institute's president and chief executive officer. For more information call 1-800-KARMANOS or go to www.karmanos.org.
SOURCE Karmanos Cancer Institute
Share this article